Clinical Trial Update: Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update reporting on completed study comparing hypo-fractionated IMRT versus conventional IMRT for unfavorable intermediate- and high-risk prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Tanta University | Conditions: Hypofractionated Dose, Prostate Cancer Patients | NA | Status: COMPLETED